Long-term safety and efficacy of pegunigalsidase alfa: A multicenter extension study in adult patients with Fabry disease

被引：0
|
作者：
Hughes, Derralynn [1 ]
Gonzalez, Derlis [2 ]
Maegawa, Gustavo [3 ]
Bernat, John [4 ]
Holida, Myrl [4 ]
Giraldo, Pilar [5 ]
Atta, Mohamed [6 ]
Chertkoff, Raul [7 ]
Alon, Sari [7 ]
Almon, Einat B. [7 ]
Rocco, Rossana [8 ]
Goker-Alpan, Ozlem [9 ]
机构：
[1] UCL, London, England
[2] Inst Privado Hematol & Invest Clin, Asuncion, Paraguay
[3] Univ Florida, Gainesville, FL USA
[4] Univ Iowa Hlth Care, Iowa City, IA USA
[5] Hosp Dia Quiron, Zaragoza, Spain
[6] Johns Hopkins Sch Med, Baltimore, MD USA
[7] Protalix Biotherapeut, Carmiel, Israel
[8] Chiesi Farmaceut SpA, Parma, Italy
[9] Lysosomal Disorders Res & Treatment Unit, Fairfax, VA USA
来源：
MOLECULAR GENETICS AND METABOLISM | 2022年 / 135卷 / 02期
关键词：
D O I：
10.1016/j.ymgme.2021.11.143
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
128
引用
收藏
页码：S58 / S58
页数：1
相关论文
共 50 条
  • [41] Long-term safety and efficacy of atomoxetine in adult adhd japanese patients
    Hirata, Y.
    Goto, T.
    Takita, Y.
    Trazepacz, P. T.
    Allen, A. J.
    Ichikawa, H.
    Takahashi, N.
    EUROPEAN PSYCHIATRY, 2013, 28
  • [42] Long-term efficacy and safety of ustekinumab in refractory Crohn's disease patients: a multicenter retrospective experience
    Wils, P.
    Bouhnik, Y.
    Michetti, P.
    Flourie, B.
    Brixi, H.
    Bourrier, A.
    Allez, M.
    Duclos, B.
    Serrero, M.
    Buisson, A.
    Amiot, A.
    Fumery, M.
    Roblin, X.
    Peyrin-Biroulet, L.
    Filippi, J.
    Bouguen, G.
    Abitbol, V.
    Coffin, B.
    Simon, M.
    Laharie, D.
    Pariente, B.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S43 - S43
  • [43] Baseline Characteristics of Patients With Fabry Disease Enrolled in the Pegunigalsidase Alfa Expanded-Access Program
    Mehta, Ankit
    Wilcox, William
    Nedd, Khan J.
    Bernat, John A.
    Knoll, Jasmine
    Jefferies, John L.
    Longo, Nicola
    Wallace, Eric L.
    Almon, Einat
    Alon, Sari
    Chertkoff, Raul
    Sullivan, Dawn
    Rocco, Rossana
    Koulinska, Irene
    Goker-Alpan, Ozlem
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 417 - 417
  • [44] AGALSIDASE ALFA LONG-TERM EFFECT ON LEFT VENTRICULAR HYPERTROPHY IN FABRY DISEASE
    Ferrari, Gustavo
    Kisinovsky, Isaac
    Reisin, Ricardo
    Rozenfeld, Paula
    Neumann, Pablo
    Finn, Veronica
    Marchesoni, Cintia
    Quieto, Pedro
    MEDICINA-BUENOS AIRES, 2024, 84 (03) : 516 - 525
  • [45] Long-term therapy with agalsidase alfa for Fabry disease: safety and effects on renal function in a home infusion setting
    Schiffmann, R
    Ries, M
    Timmons, M
    Flaherty, JT
    Brady, RO
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 (02) : 345 - 354
  • [46] Evaluation of the Long-Term Safety and Efficacy of Pegcetacoplan Treatment for Paroxysmal Nocturnal Hemoglobinuria Patients: An Extension Study
    Hoffman, Kate
    Machaidze, Zurab
    Yeh, Michael
    Weitz, Ilene C.
    BLOOD, 2021, 138
  • [47] Reduction of Globotriaosylceramide Inclusions in Renal Peritubular Capillaries in Patients with Fabry Disease Following Treatment with Pegunigalsidase Alfa
    Barisoni, Laura
    Jennette, J. Charles
    Holida, Myrl D.
    Goker-Alpan, Ozlem
    Maegawa, Gustavo
    Giraldo, Pilar
    Gonzalez, Derlis E.
    Tuffaha, Ahmad M.
    Alon, Sari
    Almon, Einat
    Chertkoff, Raul
    Hughes, Derralynn
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 595 - 595
  • [48] Long-term, Multicenter Study of the Safety and Efficacy of Topical Alprostadil Cream in Male Patients with Erectile Dysfunction
    Rooney, Michael
    Pfister, William
    Mahoney, Mary
    Nelson, Melissa
    Yeager, James
    Steidle, Christopher
    JOURNAL OF SEXUAL MEDICINE, 2009, 6 (02): : 520 - 534
  • [49] Long-term effectiveness of agalsidase alfa enzyme replacement in Fabry disease: A Fabry Outcome Survey analysis
    Beck, Michael
    Hughes, Derralynn
    Kampmann, Christoph
    Larroque, Sylvain
    Mehta, Atul
    Pintos-Morell, Guillem
    Ramaswami, Uma
    West, Michael
    Wijatyk, Anna
    Giugliani, Roberto
    MOLECULAR GENETICS AND METABOLISM REPORTS, 2015, 3 : 21 - 27
  • [50] Long-term effectiveness of agalsidase alfa enzyme replacement in Fabry disease: A Fabry Outcome Survey analysis
    Beck, Michael
    Hughes, Derralynn
    Kampmann, Christoph
    Larroque, Sylvain
    Mehta, Atul
    Pintos-Morell, Guillem
    Ramaswami, Uma
    West, Michael
    Wijatyk, Anna
    Giugliani, Roberto
    MOLECULAR GENETICS AND METABOLISM, 2015, 114 (02) : S19 - S20
12345